CS
CTSO icon

Credit Suisse’s Cytosorbents Corp CTSO Stock Holding History

Credit Suisse’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22
Closed – – 4079
2022
Q2 		$0 Buy
+22
New +$51 ﹤0.01% 3995
2021
Q1 		– Sell
-11,792
Closed -$94K – 4336
2020
Q4 		$94K Buy
+11,792
New +$98.7K ﹤0.01% 4188
2019
Q4 		– Sell
-10,620
Closed -$53K – 4182
2019
Q3 		$53K Sell
10,620
-5,131
-33% -$29.8K ﹤0.01% 4028
2019
Q2 		$104K Buy
+15,751
New +$108K ﹤0.01% 3945
2018
Q2 		– Sell
-13,868
Closed -$98K – 3997
2018
Q1 		$98K Sell
13,868
-10,280
-43% -$77.7K ﹤0.01% 3799
2017
Q4 		$157K Buy
+24,148
New +$154K ﹤0.01% 3787
2016
Q2 		– Sell
-25,527
Closed -$100K – 4219
2016
Q1 		$100K Buy
25,527
+10,971
+75% +$47.6K ﹤0.01% 3826
2015
Q4 		$81K Buy
+14,556
New +$99.1K ﹤0.01% 4090

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Credit Suisse's CTSO Position: Q3 2022 in Review

Credit Suisse sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 22 shares.

Credit Suisse first reported a position in CTSO in Q4 2015 and held it in 8 quarters. The position peaked at $157K in Q4 2017. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Credit Suisse reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 22 Cytosorbents Corp shares in Q3 2022.
  • Credit Suisse first reported a position in Cytosorbents Corp in Q4 2015 and held it in 8 quarters.
  • Credit Suisse's Cytosorbents Corp position peaked at $157K in Q4 2017.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.